Loading…
Lobbying Spend
—
Filings
16
Firms Hired
1
Active Period
2023–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: HR 6434
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: HR 6434
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: S.3346
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: S.3346
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: HR 6434
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: HR 6434
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: S.3346
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: S.3346
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: HR 6434
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: HR 6434
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: S.3346
Lobbied to garner support and reintroduction of the Freedom to Heal act HR 6434/S.3346
Client expense: — · Firm income: $20,000
Matched citations: S.3346
Wildfire Response Improvement Act
2025 · second_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
Tule River Tribe Reserved Water Rights Settlement Act of 2025
2025 · second_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: S. 689
Wildfire Response Improvement Act
2025 · first_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
Wildfire Response Improvement Act
2025 · first_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
Tule River Tribe Reserved Water Rights Settlement Act of 2025
2025 · first_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: S. 689
Tule River Tribe Reserved Water Rights Settlement Act of 2025
2025 · first_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: S. 689
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
2024 · fourth_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
2024 · fourth_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S.5132, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
Lobbied to garner support and cosponsors on H.R. 1393 and S.5132, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: S.5132
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
2024 · fourth_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: S. 689
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
2024 · third_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S. 689, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
2024 · third_quarter · Firm: THE VOGEL GROUP
Lobbied to garner support and cosponsors on H.R. 1393 and S.5132, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: H.R. 1393
Lobbied to garner support and cosponsors on H.R. 1393 and S.5132, The Breakthrough Therapies Act
Client expense: — · Firm income: $15,000
Matched citations: S.5132
Source: Senate LDA